SCHEMBL523519

SCHEMBL523519

C=C(CCCCN(CCC)CCC)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 5/20 0.45
KDM4C Q9H3R0 3/20 0.42
PHF8 Q9UPP1 2/20 0.42
DRD2 P14416 1/20 0.37
DRD4 P21917 1/20 0.37
DRD3 P35462 1/20 0.37
ICMT O60725 1/20 0.36
ALB P02768 1/20 0.36
THRB P10828 1/20 0.36
FNTA P49354 1/20 0.36
FNTB P49356 1/20 0.36
PGGT1B P53609 1/20 0.36
AKR1B1 P15121 1/20 0.35
TBXAS1 P24557 1/20 0.35
PPARG P37231 6/20 0.34
PPARD Q03181 6/20 0.34
PPARA Q07869 6/20 0.34
GPR84 Q9NQS5 5/20 0.34
HDAC11 Q96DB2 5/20 0.34
TSHR P16473 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5191395 0.98 KDM5A (0.45) KDM5AKDM4CPHF8ICMTALB
SCHEMBL2041654 0.98 KDM5A (0.45) KDM5AKDM4CPHF8ICMTALB
SCHEMBL210711 0.94 KDM5A (0.39) KDM5AKDM4CPHF8DRD2DRD4
SCHEMBL2124290 0.92 KDM5A (0.53) KDM5AKDM4CPHF8ICMTALB
SCHEMBL3387353 0.91 KDM5A (0.53) KDM5AKDM4CPHF8ICMTALB
SCHEMBL1364896 0.91 KDM5A (0.53) KDM5AKDM4CPHF8ICMTALB
SCHEMBL3896371 0.91 KDM5A (0.53) KDM5AKDM4CPHF8ICMTALB
SCHEMBL5191741 0.91 KDM5A (0.53) KDM5AKDM4CPHF8ICMTALB
Acetic Acid SCHEMBL18139298 0.91 KDM5A (0.37) KDM5AKDM4CPHF8DRD2DRD4
SCHEMBL1666283 0.91 KDM5A (0.53) KDM5AKDM4CPHF8ICMTALB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9724288-B2 Copolymers useful as rheology modifiers and home and personal care compositions comprising said copolymers BASF SE (DE) 2017-08-08 US claimed
US-20160338939-A1 COPOLYMERS USEFUL AS RHEOLOGY MODIFIERS AND HOME AND PERSONAL CARE COMPOSITIONS COMPRISING SAID COPOLYMERS BASF SE (DE) 2016-11-24 US claimed
EP-2328547-B1 COPOLYMERS USEFUL AS RHEOLOGY MODIFIERS AND HOME AND PERSONAL CARE COMPOSITIONS BASF SE (DE) 2014-03-05 EP claimed
EP-1988873-B1 POLYMERS CONTAINING SILICONE COPOLYOL MACROMERS AND PERSONAL CARE COMPOSITIONS CONTAINING SAME LUBRIZOL ADVANCED MAT INC (US) 2013-01-09 EP claimed
EP-2039343-B1 Cosmetic compositions containing a cationic copolymer and a particular amino silicone and uses thereof OREAL (FR) 2012-12-05 EP claimed
EP-2328547-A1 COPOLYMERS USEFUL AS RHEOLOGY MODIFIERS AND HOME AND PERSONAL CARE COMPOSITIONS BASF SE (DE) 2011-06-08 EP claimed
WO-2010026097-A1 COPOLYMERS USEFUL AS RHEOLOGY MODIFIERS AND HOME AND PERSONAL CARE COMPOSITIONS BASF SE (DE) 2010-03-11 WO claimed
US-20100056647-A1 Copolymers useful as rheology modifiers and home and personal care compositions comprising said copolymers CIBA CORPORATION (US) 2010-03-04 US claimed
US-20090130038-A1 COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE CATIONIC POLYMER AND AT LEAST ONE ESTER OF A C8-C24 FATTY ACID AND OXYETHYLENATED SORBITAN COMPRISING 2 TO 10 OXYETHYLENE MOTIFS, AND COSMETIC TREATMENT METHODS EMPLOYING SAID COMPOSITIONS L'OREAL S.A. (FR) 2009-05-21 US claimed
EP-1298166-B1 RUBBER COMPOSITION JSR CORP (JP) 2007-02-21 EP claimed
EP-0472204-B1 Surface treated materials of excellent adhesion for painting layer, corrosion resistance after painting, and press formability, as well as a method of manufacturing them KOBE STEEL LTD (JP) 1996-04-24 EP claimed
WO-2023202969-A1 ANTIBACTERIAL POLYMER AND PROCESS OF PREPARING THE SAME BASF SE (DE) 2023-10-26 WO disclosed
EP-3648806-A1 BIORESORBABLE SURFACE COATING FOR DELAYING DEGRADATION Drei Lilien PVG GmbH & Co. KG (DE) 2020-05-13 EP disclosed
WO-2019008192-A1 BIORESORBABLE SURFACE COATING FOR DELAYING DEGRADATION DREI LILIEN PVG GMBH & CO. KG (DE) 2019-01-10 WO disclosed
US-9724288-B2 Copolymers useful as rheology modifiers and home and personal care compositions comprising said copolymers BASF SE (DE) 2017-08-08 US disclosed
WO-2001029106-A1 METHOD FOR PRODUCING AN AQUEOUS DISPERSION OF PARTICLES THAT ARE MADE UP OF POLYMERS AND INORGANIC SOLID MATTER WHICH CONSISTS OF FINE PARTICLES BASF AKTIENGESELLSCHAFT (DE) 2001-04-26 WO disclosed
EP-0756606-B1 Use of homo- and copolymers as absorbants for aqueous acids or alkalis STOCKHAUSEN CHEM FAB GMBH (DE) 1998-02-25 EP disclosed
EP-0756606-A1 Use of homo- and copolymers as absorbants for aqueous acids or alkalis STOCKHAUSEN GmbH & CO. KG (DE) 1997-02-05 EP disclosed
WO-1995027743-A1 ABSORBANTS FOR ACIDS AND ALKALIS STOCKHAUSEN GMBH & CO. KG. (DE) 1995-10-19 WO disclosed
US-4719272-A FOR CATIONIC POLYSACCHARIDE GRAFT POLYMERS NATIONAL STARCH AND CHEMICAL CORPORATION (US) 1988-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160338939-A1 COPOLYMERS USEFUL AS RHEOLOGY MODIFIERS AND HOME AND PERSONAL CARE COMPOSITIONS COMPRISING SAID COPOLYMERS PHLPP1, PHLPP2, F12 KDM5A 707/4885KDM4C 619/4885PHF8 276/4885
US-20090130038-A1 COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE CATIONIC POLYMER AND AT LEAST ONE ESTER OF A C8-C24 FATTY ACID AND OXYETHYLENATED SORBITAN COMPRISING 2 TO 10 OXYETHYLENE MOTIFS, AND COSMETIC TREATMENT METHODS EMPLOYING SAID COMPOSITIONS FABP4, FFAR4, ANXA4 KDM5A 1333/4885KDM4C 74/4885PHF8 507/4885
US-20100056647-A1 Copolymers useful as rheology modifiers and home and personal care compositions comprising said copolymers PHLPP1, PHLPP2, F12 KDM5A 707/4885KDM4C 619/4885PHF8 276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.